| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2021-09-24 19:57:50 UTC |
|---|
| Update Date | 2021-09-24 19:57:50 UTC |
|---|
| HMDB ID | HMDB0304850 |
|---|
| Secondary Accession Numbers | None |
|---|
| Metabolite Identification |
|---|
| Common Name | Avapritinib |
|---|
| Description | Avapritinib, also known as BLU-285 or ayvakit, belongs to the class of organic compounds known as n-arylpiperazines. These are organic compounds containing a piperazine ring where the nitrogen ring atom carries an aryl group. Based on a literature review a significant number of articles have been published on Avapritinib. |
|---|
| Structure | CN1C=C(C=N1)C1=CN2N=CN=C(N3CCN(CC3)C3=NC=C(C=N3)[C@@](C)(N)C3=CC=C(F)C=C3)C2=C1 InChI=1S/C26H27FN10/c1-26(28,20-3-5-22(27)6-4-20)21-13-29-25(30-14-21)36-9-7-35(8-10-36)24-23-11-18(16-37(23)33-17-31-24)19-12-32-34(2)15-19/h3-6,11-17H,7-10,28H2,1-2H3/t26-/m0/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| (1S)-1-(4-Fluorophenyl)-1-(2-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrrolo(2,1-F)(1,2,4)triazin-4-yl)-1-piperazinyl)-5-pyrimidinyl)ethanamine | HMDB | | BLU-285 | HMDB | | Ayvakit | HMDB |
|
|---|
| Chemical Formula | C26H27FN10 |
|---|
| Average Molecular Weight | 498.57 |
|---|
| Monoisotopic Molecular Weight | 498.240419072 |
|---|
| IUPAC Name | (1S)-1-(4-fluorophenyl)-1-(2-{4-[6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl]piperazin-1-yl}pyrimidin-5-yl)ethan-1-amine |
|---|
| Traditional Name | (1S)-1-(4-fluorophenyl)-1-(2-{4-[6-(1-methylpyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl]piperazin-1-yl}pyrimidin-5-yl)ethanamine |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CN1C=C(C=N1)C1=CN2N=CN=C(N3CCN(CC3)C3=NC=C(C=N3)[C@@](C)(N)C3=CC=C(F)C=C3)C2=C1 |
|---|
| InChI Identifier | InChI=1S/C26H27FN10/c1-26(28,20-3-5-22(27)6-4-20)21-13-29-25(30-14-21)36-9-7-35(8-10-36)24-23-11-18(16-37(23)33-17-31-24)19-12-32-34(2)15-19/h3-6,11-17H,7-10,28H2,1-2H3/t26-/m0/s1 |
|---|
| InChI Key | DWYRIWUZIJHQKQ-SANMLTNESA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as n-arylpiperazines. These are organic compounds containing a piperazine ring where the nitrogen ring atom carries an aryl group. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Diazinanes |
|---|
| Sub Class | Piperazines |
|---|
| Direct Parent | N-arylpiperazines |
|---|
| Alternative Parents | |
|---|
| Substituents | - N-arylpiperazine
- Pyrrolo[2,1-f][1,2,4]triazine
- Dialkylarylamine
- Aralkylamine
- Halobenzene
- Fluorobenzene
- Aminopyrimidine
- 1,2,4-triazine
- Imidolactam
- Benzenoid
- Triazine
- Substituted pyrrole
- Pyrimidine
- Monocyclic benzene moiety
- Aryl halide
- Aryl fluoride
- Heteroaromatic compound
- Pyrrole
- Pyrazole
- Azole
- Azacycle
- Organic nitrogen compound
- Organopnictogen compound
- Hydrocarbon derivative
- Primary amine
- Organonitrogen compound
- Organofluoride
- Organohalogen compound
- Primary aliphatic amine
- Amine
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Predicted by Siyang on May 30, 2022 | 11.6239 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 3.38 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1811.5 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 222.2 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 222.5 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 171.6 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 169.1 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 567.7 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 443.9 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 129.7 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1292.1 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 459.1 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1676.2 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 341.1 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 375.9 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 242.6 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 206.5 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 8.2 seconds | 40023050 |
Predicted Kovats Retention IndicesDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Avapritinib,1TMS,isomer #1 | CN1C=C(C2=CN3N=CN=C(N4CCN(C5=NC=C([C@@](C)(N[Si](C)(C)C)C6=CC=C(F)C=C6)C=N5)CC4)C3=C2)C=N1 | 4964.1 | Semi standard non polar | 33892256 | | Avapritinib,1TMS,isomer #1 | CN1C=C(C2=CN3N=CN=C(N4CCN(C5=NC=C([C@@](C)(N[Si](C)(C)C)C6=CC=C(F)C=C6)C=N5)CC4)C3=C2)C=N1 | 4497.6 | Standard non polar | 33892256 | | Avapritinib,1TMS,isomer #1 | CN1C=C(C2=CN3N=CN=C(N4CCN(C5=NC=C([C@@](C)(N[Si](C)(C)C)C6=CC=C(F)C=C6)C=N5)CC4)C3=C2)C=N1 | 6154.4 | Standard polar | 33892256 | | Avapritinib,2TMS,isomer #1 | CN1C=C(C2=CN3N=CN=C(N4CCN(C5=NC=C([C@](C)(C6=CC=C(F)C=C6)N([Si](C)(C)C)[Si](C)(C)C)C=N5)CC4)C3=C2)C=N1 | 4863.1 | Semi standard non polar | 33892256 | | Avapritinib,2TMS,isomer #1 | CN1C=C(C2=CN3N=CN=C(N4CCN(C5=NC=C([C@](C)(C6=CC=C(F)C=C6)N([Si](C)(C)C)[Si](C)(C)C)C=N5)CC4)C3=C2)C=N1 | 4561.9 | Standard non polar | 33892256 | | Avapritinib,2TMS,isomer #1 | CN1C=C(C2=CN3N=CN=C(N4CCN(C5=NC=C([C@](C)(C6=CC=C(F)C=C6)N([Si](C)(C)C)[Si](C)(C)C)C=N5)CC4)C3=C2)C=N1 | 5977.1 | Standard polar | 33892256 | | Avapritinib,1TBDMS,isomer #1 | CN1C=C(C2=CN3N=CN=C(N4CCN(C5=NC=C([C@@](C)(N[Si](C)(C)C(C)(C)C)C6=CC=C(F)C=C6)C=N5)CC4)C3=C2)C=N1 | 5167.0 | Semi standard non polar | 33892256 | | Avapritinib,1TBDMS,isomer #1 | CN1C=C(C2=CN3N=CN=C(N4CCN(C5=NC=C([C@@](C)(N[Si](C)(C)C(C)(C)C)C6=CC=C(F)C=C6)C=N5)CC4)C3=C2)C=N1 | 4688.1 | Standard non polar | 33892256 | | Avapritinib,1TBDMS,isomer #1 | CN1C=C(C2=CN3N=CN=C(N4CCN(C5=NC=C([C@@](C)(N[Si](C)(C)C(C)(C)C)C6=CC=C(F)C=C6)C=N5)CC4)C3=C2)C=N1 | 6115.6 | Standard polar | 33892256 | | Avapritinib,2TBDMS,isomer #1 | CN1C=C(C2=CN3N=CN=C(N4CCN(C5=NC=C([C@](C)(C6=CC=C(F)C=C6)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=N5)CC4)C3=C2)C=N1 | 5197.1 | Semi standard non polar | 33892256 | | Avapritinib,2TBDMS,isomer #1 | CN1C=C(C2=CN3N=CN=C(N4CCN(C5=NC=C([C@](C)(C6=CC=C(F)C=C6)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=N5)CC4)C3=C2)C=N1 | 4937.0 | Standard non polar | 33892256 | | Avapritinib,2TBDMS,isomer #1 | CN1C=C(C2=CN3N=CN=C(N4CCN(C5=NC=C([C@](C)(C6=CC=C(F)C=C6)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=N5)CC4)C3=C2)C=N1 | 5890.7 | Standard polar | 33892256 |
|
|---|